STAT

STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more

STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and moreWorldPing

GSK has continued its drive to bulk up its pipeline, taking global rights to a multiple myeloma treatment developed in China…

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news

Russia oil squeeze, China competition, Saudi pipeline shut: India's crude crunchWorldPing
Times of India

Russia oil squeeze, China competition, Saudi pipeline shut: India's crude crunch

Where does that leave India, a country that imports around 90% of its crude oil? If crude oil prices continue to rise due to global supply constraints and Russian crude discounts ebb, will India’s crude oil bill manage another hit within months?

Brief by WorldPing · Original reporting by Times of India